Citation Impact
Citing Papers
A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors1
2004
Hepatocellular carcinoma
2018 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Hospitalizations for Bacterial Endocarditis after Initiation of Chronic Dialysis in the United States
2002
Chronic dialysis patients have high risk for pulmonary embolism
2002
Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis
1998
THE IMPACT OF DONOR AGE ON LIVER TRANSPLANTATION: INFLUENCE OF DONOR AGE ON EARLY LIVER FUNCTION AND ON SUBSEQUENT PATIENT AND GRAFT SURVIVAL
2001
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
2010 Standout
Metabolic syndrome in liver transplant recipients
2010
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation
2001
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Cardiovascular Toxicities of Immunosuppressive Agents
2002
Liver transplantation: Current status and novel approaches to liver replacement
2001
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study
2000
De novo malignancies after liver transplantation: A major cause of late death
2001
Non-alcoholic fatty liver disease and liver transplantation
2016
Prevention of Venous Thromboembolism
2004 Standout
Paradoxical roles of the immune system during cancer development
2006 Standout
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
A Comparison of Tacrolimus and Cyclosporine in Liver Transplantation: Effects on Renal Function and Cardiovascular Risk Status
2005
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
2012 Standout
Independent risk factors and natural history of renal dysfunction in liver transplant recipients
2003
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Infective endocarditis
2004 Standout
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
2017
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
De Novo Neoplasia After Liver Transplantation: An Analysis of Risk Factors and Influence on Survival
2004
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Risk of Malignant Neoplasms After Liver Transplantation: A Population-Based Study
2008
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
RAPAMYCIN PROTECTS ALLOGRAFTS FROM REJECTION WHILE SIMULTANEOUSLY ATTACKING TUMORS IN IMMUNOSUPPRESSED MICE
2004
Works of Gülüm Altaca being referenced
Living donor liver transplantation for obese patients: Challenges and outcomes
2013
SAFE USE OF HEPATIC ALLOGRAFTS FROM DONORS OLDER THAN 70 YEARS1
1996
LONG-TERM MEDICAL COMPLICATIONS IN PATIENTS SURVIVING ???5 YEARS AFTER LIVER TRANSPLANT
2000
1996